Search
Products
Community
Markets
News
Brokers
More
EN
Get started
Community
/
Ideas
/
LABU Triple Leveraged Biotech Sector ETF
Direxion Daily S&P Biotech Bull 3X Shares
Long
LABU Triple Leveraged Biotech Sector ETF
By AwesomeAvani
Follow
Follow
May 3, 2023
0
Cheer
Cheer
May 3, 2023
On the 4H Chart LABU is trending up since March 27th. Last week there was a small pullback which was met with more buying activity.
On the volume indicator, the volume now is approximately 10X day by day compared with March's averages. It is this buying that is driving
the bullish momentum. Small-cap speculative biotech companies are in a growth mode right now no matter adverse economic conditions
for those yet to have any earnings. Big pharma is more concerned about federal attempts to further regulate prices than the economy.
On the volume profile, price has ascended to above the high volume trading area on the strength of buyer interest propelling the
momentum. Overall, this looks to be a decent long trade. The target is $ 9.00 the YTD high back in February.
bigpharma
biotech
biotechnology
LABU
Trend Lines
Volume
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the
Terms of Use
.